Male Performance Enhancer Recalled for Undeclared Sildenafil and Tadalafil
ALPHASTRIP Male Performance Enhancer strips are being recalled nationwide because they contain undeclared sildenafil and tadalafil. The product was marketed without FDA approval.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I recalls are never scored below Severe (4) per the rubric. No illnesses or injuries have been reported. The Class I designation reflects serious potential for adverse health consequences due to the presence of unapproved prescription drugs.
Plain-English summary
ALPHASTRIP Male Performance Enhancer is a sublingual strip product manufactured by Pyramids Wholesale Inc. and distributed by GALT INT'L. The FDA has recalled all lots of the product due to the discovery of undeclared sildenafil and tadalafil.
The product was marketed without an FDA-approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA). The recall designation is Class I. A total of 4,351 pieces were distributed nationwide.
Consumers who have obtained or used ALPHASTRIP should stop using the product immediately and contact a healthcare provider, especially if they experience any adverse symptoms or have underlying health conditions or take other medications.
The recalled product
- Product
- ALPHASTRIP MALE PERFORMANCE ENHANCER, The fastest acting sublingual, Serving Size (1 strip), Distributed by: GALT INT'L
- Manufacturer
- Pyramids Wholesale Inc.
- Hazard
- undeclared-sildenafil
- undeclared-tadalafil
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27